Advances in anticancer radiopharmaceuticals.
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discov...
Hoofdauteurs: | Jackson, MR, Falzone, N, Vallis, K |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2013
|
Gelijkaardige items
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
door: Cornelissen, B, et al.
Gepubliceerd in: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
door: Cornelissen, B, et al.
Gepubliceerd in: (2012) -
Targeted radionuclide therapy: new advances for improvement of patient management and response
door: Malcolm, J, et al.
Gepubliceerd in: (2019) -
Radiopharmaceuticals for imaging and therapy.
door: Faulkner, S, et al.
Gepubliceerd in: (2011) -
Regulation of Radiopharmaceutical Products
door: V. V. Kosenko, et al.
Gepubliceerd in: (2022-12-01)